DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,606,696 | +67.2% | 6,476 | +61.8% | 2.37% | +114.4% |
| Q2 2023 | $960,720 | -7.7% | 4,003 | -3.1% | 1.10% | -19.8% |
| Q1 2023 | $1,040,673 | -40.6% | 4,129 | -37.5% | 1.38% | -40.6% |
| Q4 2022 | $1,753,099 | +8.6% | 6,605 | +5.7% | 2.32% | +12.5% |
| Q3 2022 | $1,614,000 | +34.9% | 6,249 | +32.5% | 2.06% | +77.7% |
| Q2 2022 | $1,196,000 | -50.7% | 4,717 | -43.0% | 1.16% | -33.5% |
| Q1 2022 | $2,428,000 | -2.1% | 8,279 | +9.8% | 1.74% | -4.3% |
| Q4 2021 | $2,481,000 | +72.3% | 7,541 | +59.4% | 1.82% | +56.4% |
| Q3 2021 | $1,440,000 | +14.7% | 4,730 | +1.1% | 1.16% | +38.5% |
| Q2 2021 | $1,255,000 | +20.6% | 4,677 | +1.1% | 0.84% | +1.4% |
| Q1 2021 | $1,041,000 | -62.5% | 4,627 | -63.0% | 0.83% | -65.7% |
| Q4 2020 | $2,777,000 | +4.2% | 12,502 | +1.0% | 2.41% | -4.4% |
| Q3 2020 | $2,666,000 | +21.3% | 12,381 | -0.3% | 2.52% | +13.5% |
| Q2 2020 | $2,197,000 | +96.7% | 12,422 | +53.9% | 2.22% | -37.8% |
| Q1 2020 | $1,117,000 | -10.1% | 8,071 | -0.4% | 3.57% | +56.1% |
| Q4 2019 | $1,243,000 | +6.0% | 8,101 | -0.2% | 2.29% | -48.3% |
| Q3 2019 | $1,173,000 | +1.0% | 8,119 | -0.0% | 4.43% | -13.5% |
| Q2 2019 | $1,161,000 | +7.0% | 8,120 | -1.2% | 5.12% | +11.2% |
| Q1 2019 | $1,085,000 | +29.3% | 8,217 | +0.9% | 4.60% | +302.6% |
| Q4 2018 | $839,000 | – | 8,141 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |